Intravenous Immunoglobulin Market Trends Shaping Global Consumption and Production
Market Overview According to the research report, the global intravenous immunoglobulin market was valued at USD 12.66 billion in 2023 and is expected to reach USD 24.13 billion by 2032, to grow at a CAGR of 7.50% during the forecast period. Intravenous immunoglobulin (IVIG) is a blood plasma-derived product composed of pooled immunoglobulin G (IgG) antibodies extracted from the plasma of thousands of donors. It is administered intravenously to patients suffering from primary and secondary immunodeficiencies, autoimmune disorders, inflammatory diseases, and neurological conditions such as Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP). Due to its ability to modulate the immune response and neutralize harmful pathogens or autoantibodies, IVIG plays a vital role in treating conditions where the immune system is compromised or overactive. The market has grown consistently in the last decade, bolstered by improvements in plasma fracti...